You are being directed to ZacksTrade, a division of Zacks & Company and licensed broker-dealer. ZacksTrade and Zacks.com are separate but affiliated companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.

If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.

OK Cancel

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 04/22/2014

Company Name Symbol %Change
CELL THERAPE CTIC
11.37%
CANADIAN SOL CSIQ
9.45%
ZIOPHARM ONC ZIOP
8.26%
ENANTA PHARM ENTA
7.38%
MOTORCAR PAR MPAA
7.29%

Todd Bunton

Services :

Interests :

  • Stock Research
  • Investor Education
  • Long-term Investing
  • Earnings Surprises
  • Growth & Income

Connect :

Share
Todd Bunton

Stock Strategist

RSS Feed | Email This Author

Latest Comments on Todd Bunton's Articles

About

Todd Bunton, CFA is editor of the Income Plus Investor service, which focuses on finding low risk, high-yielding stocks and ETFs. He joined Zacks Investment Research in 2010 as the Growth & Income Stock Strategist. Prior to joining Zacks, Todd worked in sell side equity research covering bank stocks. He graduated from the Kelley School of Business at Indiana University in 2005 where he majored in finance. Mr. Bunton earned his CFA charter in 2013.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.